Aroa Biosurgery Limited (ARX) is a soft tissue regeneration company focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. It participates in the wound care and surgical reconstruction markets. Its products currently for sale in the key US market target chronic wounds and soft tissue reconstruction including, hernia, breast reconstruction and trauma/limb salvage/ tumour surgery.
Aroa Biosurgery Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.aroabio.com.
This a small cap company with market cap of 360 millions.
Compared to Market and Sector
The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.
Company PE is less than both sector and market. while On the other hand, Company Earning is greater than both sector and market.
Dividend Growth Chart
The following chart shows you how arx dividend grows in the recent years.